Charlotte's Web Holdings (CWBHF) Shares Outstanding (Diluted Average) (2020 - 2023)
Charlotte's Web Holdings (CWBHF) reported Shares Outstanding (Diluted Average) of $152.3 million for Q1 2023, up 5.05% year-over-year from $145.0 million in Q1 2022, and up 3.88% quarter-over-quarter from $146.6 million in Q4 2022.
Charlotte's Web Holdings (CWBHF) Shares Outstanding (Diluted Average) (2020 - 2023) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 4 years of Shares Outstanding (Diluted Average) data on file, last reported at $152.3 million in Q1 2023.
- Shares Outstanding (Diluted Average) for Q1 2023 came in at $152.3 million, up 5.05% year-over-year; the trailing twelve-month figure through Mar 2023 was $152.3 million (up 5.05% YoY), and the FY2022 annual result was $146.6 million, up 4.16% from the prior year.
- Shares Outstanding (Diluted Average) rose to $152.3 million in Q1 2023 per CWBHF's latest filing, from $146.6 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $152.3 million in Q1 2023 and troughed at $125.0 million in Q4 2020.
- A 4-year average of $142.0 million and a median of $142.9 million in 2021 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) increased 12.6% in 2021, then climbed 3.43% in 2022.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $125.0 million in 2020, then gained by 12.6% to $140.8 million in 2021, then increased by 4.16% to $146.6 million in 2022, then climbed by 3.88% to $152.3 million in 2023.
- Business Quant data shows CWBHF's Shares Outstanding (Diluted Average) at $152.3 million in Q1 2023, $146.6 million in Q4 2022, and $145.3 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Charlotte's Web Holdings | - | - | 5.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 152.31 Mn |
| Dec 31, 2022 | 146.63 Mn |
| Sep 30, 2022 | 145.33 Mn |
| Jun 30, 2022 | 145.08 Mn |
| Mar 31, 2022 | 144.99 Mn |
| Dec 31, 2021 | 140.77 Mn |
| Sep 30, 2021 | 140.52 Mn |
| Jun 30, 2021 | 139.94 Mn |
| Mar 31, 2021 | 139.70 Mn |
| Dec 31, 2020 | 125.01 Mn |